One research focus relates to the interaction between cancer cells and their microenvironment, and how the tumor can circumvent the immunosurveillance, called immune editing, and the new line of immunotherapies directed against them, e.g. check-point inhibitors.
2024
Critical reviews in oncology/hematology, Elsevier 2024, Vol. 195
Rosell, Rafael; Codony-Servat, Jordi; González, Jessica; et al.
2023
BMC Complementary Medicine and Therapies, BioMed Central (BMC) 2023, Vol. 23, (1)
Källman, Mikael; Bergström, Stefan; Carlsson, Tobias; et al.
2022
Cancer Cell, Elsevier 2022, Vol. 40, (9) : 999-1009.e6
In ’t Veld, Sjors G.J.G.; Arkani, Mohammad; Post, Edward; et al.
2022
Molecular Oncology, John Wiley & Sons 2022, (4)
Thysell, Elin; Köhn, Linda; Semenas, Julius; et al.
2020
Cell Reports Medicine, Elsevier 2020, Vol. 1, (7)
Sol, Nik; 't Veld, Sjors G. J. G. in; Vancura, Adrienne; et al.
2018
The Prostate, Wiley-Blackwell 2018, Vol. 78, (1) : 48-53
Tjon-Kon-Fat, Lee-Ann; Lundholm, Marie; Schröder, Mona; et al.
2018
Seminars in Thrombosis and Hemostasis, THIEME MEDICAL PUBL INC 2018, Vol. 44, (2) : 135-141
Tjon-Kon-Fat, Lee-Ann; Sol, Nik; Wurdinger, Thomas; et al.
2017
Cancer Cell, Elsevier 2017, Vol. 32, (2) : 238-252
Best, Myron G.; Sol, Nik; 't Veld, Sjors G. J. G. In; et al.
2017
Asian Pacific Journal of Cancer Prevention, Vol. 18, (6) : 1555-1560
Holgersson, Georg; Bergqvist, Michael; Nilsson, R. Jonas A.; et al.